Cargando…

Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells

In 2016, as part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Vanden Heuvel et al., 2016), that described how we intended to replicate selected experiments from the paper ‘Systematic identification of genomic markers of drug sensitivity in cancer cells’ (Garnett...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanden Heuvel, John P, Maddox, Ewa, Maalouf, Samar W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760202/ https://www.ncbi.nlm.nih.gov/pubmed/29313488 http://dx.doi.org/10.7554/eLife.29747

Ejemplares similares

Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells
por: Vanden Heuvel, John P, et al.
Publicado: (2016)

Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
por: Mantis, Christine, et al.
Publicado: (2017)

Ectokinases as novel cancer markers and drug targets in cancer therapy
por: Yalak, Garif, et al.
Publicado: (2015)

Accumulating evidence to support the safe and efficacious use of a proprietary blend of capsaicinoids in mediating risk factors for obesity
por: Mariwala, Javahar Kohli, et al.
Publicado: (2021)

Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
por: Zheng, Hui, et al.
Publicado: (2020)

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
por: Franklin, Miriam, et al.
Publicado: (2018)

Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
por: Horrigan, Stephen K, et al.
Publicado: (2017)

The challenges of replication
Publicado: (2017)

Investigating the replicability of preclinical cancer biology
por: Errington, Timothy M, et al.
Publicado: (2021)

Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data
por: Kandela, Irawati, et al.
Publicado: (2017)

Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
por: Miralaei, Noushin, et al.
Publicado: (2021)

Making sense of replications
por: Nosek, Brian A, et al.
Publicado: (2017)

Challenges for assessing replicability in preclinical cancer biology
por: Errington, Timothy M, et al.
Publicado: (2021)

Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
por: Repass, John
Publicado: (2018)

Systematic identification of genomic markers of drug sensitivity in cancer cells
por: Garnett, Mathew J., et al.
Publicado: (2012)

Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
por: Smith, Joan C, et al.
Publicado: (2018)

Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota
por: Eaton, Kathryn, et al.
Publicado: (2018)

Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand
por: Ara, Mst Naznin, et al.
Publicado: (2014)

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance
por: Pech, Matthew F, et al.
Publicado: (2019)

Identification of differential expressed lncRNAs in human thyroid cancer by a genome‐wide analyses
por: Lu, Wei, et al.
Publicado: (2018)

Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas
por: Tanimoto, Kousuke, et al.
Publicado: (2019)

Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
por: Kerwin, John, et al.
Publicado: (2020)

Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
por: Essex, Anthony, et al.
Publicado: (2019)

Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations
por: Yoshida, Noriaki, et al.
Publicado: (2012)

Identification of dysregulated lncRNAs profiling and metastasis‐associated lncRNAs in colorectal cancer by genome‐wide analysis
por: Chen, Yan, et al.
Publicado: (2017)

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
por: Lewis, L Michelle, et al.
Publicado: (2018)

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer
por: Krall, Elsa B, et al.
Publicado: (2017)

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2017)

53BP1 and BRCA1 control pathway choice for stalled replication restart
por: Xu, Yixi, et al.
Publicado: (2017)

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
por: Shan, Xiaochuan, et al.
Publicado: (2017)

Xanthine oxidoreductase in cancer: more than a differentiation marker
por: Battelli, Maria Giulia, et al.
Publicado: (2015)

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
por: Kolluri, Krishna Kalyan, et al.
Publicado: (2018)

Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer
por: Krall, Elsa Beyer, et al.
Publicado: (2017)

Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
por: Wang, Hongyan, et al.
Publicado: (2020)

Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
por: Sheen, Mee Rie, et al.
Publicado: (2019)

Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
por: Chen, Huan-Huan, et al.
Publicado: (2022)

Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered region
por: Balasubramanian, Sandhya, et al.
Publicado: (2022)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells
por: Li, Jin‐Li, et al.
Publicado: (2019)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mmb2lo74e4pp02uspgk9mmehtd